Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK/PD study of recombinant human interferon alpha-2b injection in healthy volunteers
ChiCTR2100041760Phase 4Recruiting
- Sponsor
- The First People's Hospital of Nanning
- Start
- Feb 2021
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of interferon alfa-2b in viral hepatitis, herpes zoster (HZ), anogenital warts and 2 more, sponsored by The First People's Hospital of Nanning. Primary endpoints: AUC0-t, Cmax and 4 more. Started Feb 2021; status: recruiting.
02
Drugs
interferon alfa-2b
03
Conditions
viral hepatitisherpes zoster (HZ)anogenital wartshairy cell leukemia (HCL)chronic myelogenous leukemia (CML)
Beyond the preview
Go deeper on ChiCTR2100041760.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100041760.